MEDI
Harbor Health Care ETF
MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally.
Global
EQUITY
Active
MANAGEMENT STYLE
16.4 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Fund sponsor | ORIX |
| Category | Global |
| Asset class | Equity |
| Website | link... |
| Inception date | Nov 17, 2022 |
| Assets (mns) | $16 |
| Expense ratio | 80 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Annually |
| Taxation | 1099 |
| Stock selection | Proprietary |
| Weighting | Proprietary |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ASCENDIS PHARMA A/S | 14.2 % |
| ABBVIE INC | 10.6 % |
| LEGEND BIOTECH CORPORATION SPONSORED ADR | 7.7 % |
| MASIMO CORPORATION | 6.0 % |
| PFIZER INC | 5.7 % |
| UNITEDHEALTH GROUP INC | 5.1 % |
| SANOFI-AVENTIS-ADR | 3.6 % |
| OPTION CARE HEALTH INC | 3.5 % |
| VAXCYTE, INC. | 2.8 % |
| INNOVIVA, INC. | 2.8 % |
Constituent Breakdown
| Number of holdings | 39 |
| Herfindahl-Hirschman Index | 563 |
| Wgt avg mkt cap (mns) | $100,238 |
| Large cap (>$10bn) | 46.5% |
| Mid cap ($2-10bn) | 47.5% |
| Small cap (<$2bn) | 6.0% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Country Exposure
 |
UNITED STATES | 71.7 % |
 |
DENMARK | 14.2 % |
 |
FRANCE | 3.6 % |
 |
IRELAND | 2.9 % |
 |
NETHERLANDS | 1.4 % |
 |
SWITZERLAND | 0.8 % |
Historical Performance
Standardized Performance (as of 11/30/2024)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | Incep. | |
|---|---|---|---|---|---|---|---|
| Total Returns | 6.2% | 15.3% | -- | -- | -- | -- | 15.8% | Volatility | 15.3% | 15.5% | -- | -- | -- | -- | -- |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.94 | 59% |
| MSCI EAFE | 0.81 | 57% |
| MSCI Emg Mkts | 0.68 | 35% |
Liquidity Measures
| Avg. volume (000) | 2 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.42% |
| ADV of underlying (mns) | $9,404 |
Technical Indicators
| Recent close | $25.24 |
| 30d moving avg. | $26.10 |
| Annualized volatility | 15.6% |
| Relative strength (RSI) | 44 |
| Short interest (ETF) | 0.5% |
| Short interest (underlying) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MEDI |
Expenses vs. MEDI |
ALTAR Score™ vs. MEDI |
|---|---|---|---|---|
| IYH | iShares U.S. Healthcare ETF | 23.5% | -40 bp | +5.5% |
| BHCHX | Baron Health Care Strategy | 23.4% | -5 bp | -2.3% |
| FHLC | Fidelity MSCI Health Care Index ETF | 23.0% | -72 bp | +4.8% |
| XLV | Health Care Select Sector SPDR Fund | 22.5% | -71 bp | +6.3% |
| VHT | Vanguard Health Care ETF | 22.2% | -70 bp | +4.5% |
| FMED | Fidelity Disruptive Medicine ETF | 22.0% | -30 bp | -1.9% |
| IXJ | iShares Global Healthcare ETF | 19.0% | -38 bp | +5.4% |
| PINK | Simplify Health Care ETF | 18.5% | -30 bp | +2.0% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 17.4% | -40 bp | +6.3% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 17.1% | -20 bp | +8.7% |
Risk and Returns: MEDI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| 2023 | 2024E | Fwd Est | 2025E | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 12/18/2024
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
MEDI
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
UNDERWEIGHT
Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.
ALTAR Score™
MEDI
1.5%
Cat. Avg
4.2%
ALTAR Score™ Calculation
Category Overview
There are 375 funds in the Global Equity category, with an average ALTAR Score™
of 4.2% and a standard deviation of
4.8%. MEDI's ALTAR Score™ is approximately
0.6 standard deviations
below
the category average. This places MEDI in the 29th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
MEDISELL
U/W
HOLD
O/W
BUY
Expense Analysis
| Peer Group | Active Global Equity ETFs |
| # of ETFs | 118 |
| Avg. Expense Ratio | 73.5 bp |
| Std. Deviation | 29.8 bp |
| MEDI (80 bp) Percentile rank | 61 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
| Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
|---|---|---|---|
| MEDI | 80.0 | 42.2 | 122.2 |
| Peer Avg. | 74.2 | 38.8 | 113.0 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .